Method for treating meibomian gland disease
OwnerStephen C. Pflugfelder, Balakrishna L. Lokeshwar +1inventors
InventorsStephen C. Pflugfelder, Balakrishna L. Lokeshwar, Marie Selzer
Life of this patent
Estimating the term…
Abstract
A method for treating a patient having meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion, is disclosed. Preferably, the method concerns treatment of a patient with topical tetracycline, a derivative or analogue of tetracycline, or a chemically modified tetracycline (CMT). Oral administration of a CMT is also disclosed as part of the method for treating meibomian gland disease, ocular irritation associated with delayed tear clearance, or recurrent corneal epithelial erosion.
Claims27
A method of treating a patient having meibomian gland disease, aqueous tear deficiency, delayed tear clearance or recurrent corneal epithelial erosion, said method comprising:
- topically administering an effective amount of tetracycline to an eye of the patient.
A method of treating a patient having meibomian gland disease, aqueous tear deficiency, delayed tear clearance or recurrent corneal epithelial erosion, said method comprising:
- orally administering an effective amount of tetracycline to an eye of the patient.
A composition for treating a patient having meibomian gland disease, said composition comprising an antimicrobial tetracycline or a non-antimicrobial tetracycline as an active ingredient in a balanced salt solution.
Dependencies are inferred from the claim text.